Optimizing Quality of Life by Improved Patient Expectation Following Atrial Fibrillation Catheter Ablation

Last updated: November 9, 2022
Sponsor: Evangelical Hospital Düsseldorf
Overall Status: Active - Recruiting

Phase

N/A

Condition

Atrial Fibrillation

Arrhythmia

Chest Pain

Treatment

N/A

Clinical Study ID

NCT05557526
IMPROVE AF
  • Ages > 18
  • All Genders

Study Summary

The aim is to investigate whether optimizing patients' expectations towards the interventional treatment of atrial fibrillation (catheter ablation) leads to a lower disease-related impairment of the patients compared to the control group in the first three months after ablation (the so-called blanking period).

Eligibility Criteria

Inclusion

Inclusion Criteria:

  • symptomatic atrial fibrillation
  • indication for pulmonary vein isolation
  • sufficient command of the German language

Exclusion

Exclusion Criteria:

  • age <18 years
  • permanent atrial fibrillation
  • presence of psychiatric disorders which impair the study participitatin
  • presence of another medical condiction which influences quality of life stronger thanthe cardiac condition
  • atrial fibrillation induced by intoxication, medicamentation or infection
  • inability to grap the course of the study

Study Design

Total Participants: 60
Study Start date:
June 09, 2022
Estimated Completion Date:
June 30, 2024

Connect with a study center

  • Evangelic Hospital Düsseldorf

    Düsseldorf, North Rhine-Westfalia 40217
    Germany

    Active - Recruiting

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.